Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Jan 1;361(Pt 1):97–103. doi: 10.1042/0264-6021:3610097

Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.

Guy Verrijdt 1, Annemie Haelens 1, Erik Schoenmakers 1, Wilfried Rombauts 1, Frank Claessens 1
PMCID: PMC1222283  PMID: 11742533

Abstract

We performed a comparative analysis of the effect of high-mobility group box protein 1 (HMGB1) on DNA binding by the DNA-binding domains (DBDs) of the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. The affinity of the DBDs of the different receptors for the tyrosine aminotransferase glucocorticoid response element, a classical high-affinity binding element, was augmented up to 7-fold by HMGB1. We found no major differences in the effects of HMGB1 on DNA binding between the different steroid hormone receptors. In transient transfection assays, however, HMGB1 significantly enhances the activity of the glucocorticoid and progesterone receptors but not the androgen or mineralocorticoid receptor. We also investigated the effect of HMGB1 on the binding of the androgen receptor DBD to a subclass of directly repeated response elements that is recognized exclusively by the androgen receptor and not by the glucocorticoid, progesterone or mineralocorticoid receptor. Surprisingly, a deletion of 26 amino acid residues from the C-terminal extension of the androgen receptor DBD does not influence DNA binding but destroys its sensitivity to HMGB1. Deletion of the corresponding fragment in the DBDs of the glucocorticoid, progesterone and mineralocorticoid receptor destroyed their DNA binding. This 26-residue fragment is therefore essential for the influence of HMGB1 on DNA recognition by all steroid hormone receptors that were tested. However, it is dispensable for DNA binding by the androgen receptor.

Full Text

The Full Text of this article is available as a PDF (263.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aidinis V., Bonaldi T., Beltrame M., Santagata S., Bianchi M. E., Spanopoulou E. The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2. Mol Cell Biol. 1999 Oct;19(10):6532–6542. doi: 10.1128/mcb.19.10.6532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boonyaratanakornkit V., Melvin V., Prendergast P., Altmann M., Ronfani L., Bianchi M. E., Taraseviciene L., Nordeen S. K., Allegretto E. A., Edwards D. P. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol. 1998 Aug;18(8):4471–4487. doi: 10.1128/mcb.18.8.4471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bustin M., Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol. 1996;54:35–100. doi: 10.1016/s0079-6603(08)60360-8. [DOI] [PubMed] [Google Scholar]
  4. Calogero S., Grassi F., Aguzzi A., Voigtländer T., Ferrier P., Ferrari S., Bianchi M. E. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet. 1999 Jul;22(3):276–280. doi: 10.1038/10338. [DOI] [PubMed] [Google Scholar]
  5. Cato A. C., Ponta H., Herrlich P. Regulation of gene expression by steroid hormones. Prog Nucleic Acid Res Mol Biol. 1992;43:1–36. doi: 10.1016/s0079-6603(08)61042-9. [DOI] [PubMed] [Google Scholar]
  6. Claessens F., Verrijdt G., Schoenmakers E., Haelens A., Peeters B., Verhoeven G., Rombauts W. Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):23–30. doi: 10.1016/s0960-0760(00)00154-0. [DOI] [PubMed] [Google Scholar]
  7. Ellwood K. B., Yen Y. M., Johnson R. C., Carey M. Mechanism for specificity by HMG-1 in enhanceosome assembly. Mol Cell Biol. 2000 Jun;20(12):4359–4370. doi: 10.1128/mcb.20.12.4359-4370.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Falvo J. V., Thanos D., Maniatis T. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell. 1995 Dec 29;83(7):1101–1111. doi: 10.1016/0092-8674(95)90137-x. [DOI] [PubMed] [Google Scholar]
  9. Glass C. K. Some new twists in the regulation of gene expression by thyroid hormone and retinoic acid receptors. J Endocrinol. 1996 Sep;150(3):349–357. doi: 10.1677/joe.0.1500349. [DOI] [PubMed] [Google Scholar]
  10. Hofman K., Swinnen J. V., Claessens F., Verhoeven G., Heyns W. Apparent coactivation due to interference of expression constructs with nuclear receptor expression. Mol Cell Endocrinol. 2000 Oct 25;168(1-2):21–29. doi: 10.1016/s0303-7207(00)00311-7. [DOI] [PubMed] [Google Scholar]
  11. Holmbeck S. M., Foster M. P., Casimiro D. R., Sem D. S., Dyson H. J., Wright P. E. High-resolution solution structure of the retinoid X receptor DNA-binding domain. J Mol Biol. 1998 Aug 14;281(2):271–284. doi: 10.1006/jmbi.1998.1908. [DOI] [PubMed] [Google Scholar]
  12. Jantzen H. M., Strähle U., Gloss B., Stewart F., Schmid W., Boshart M., Miksicek R., Schütz G. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell. 1987 Apr 10;49(1):29–38. doi: 10.1016/0092-8674(87)90752-5. [DOI] [PubMed] [Google Scholar]
  13. Jayaraman L., Moorthy N. C., Murthy K. G., Manley J. L., Bustin M., Prives C. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev. 1998 Feb 15;12(4):462–472. doi: 10.1101/gad.12.4.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Luisi B. F., Xu W. X., Otwinowski Z., Freedman L. P., Yamamoto K. R., Sigler P. B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 1991 Aug 8;352(6335):497–505. doi: 10.1038/352497a0. [DOI] [PubMed] [Google Scholar]
  15. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. The nuclear receptor superfamily: the second decade. Cell. 1995 Dec 15;83(6):835–839. doi: 10.1016/0092-8674(95)90199-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McKenna N. J., Lanz R. B., O'Malley B. W. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999 Jun;20(3):321–344. doi: 10.1210/edrv.20.3.0366. [DOI] [PubMed] [Google Scholar]
  17. Melvin V. S., Edwards D. P. Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids. 1999 Sep;64(9):576–586. doi: 10.1016/s0039-128x(99)00036-7. [DOI] [PubMed] [Google Scholar]
  18. Murphy F. V., 4th, Sweet R. M., Churchill M. E. The structure of a chromosomal high mobility group protein-DNA complex reveals sequence-neutral mechanisms important for non-sequence-specific DNA recognition. EMBO J. 1999 Dec 1;18(23):6610–6618. doi: 10.1093/emboj/18.23.6610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. P-ohler J. R., Norman D. G., Bramham J., Bianchi M. E., Lilley D. M. HMG box proteins bind to four-way DNA junctions in their open conformation. EMBO J. 1998 Feb 2;17(3):817–826. doi: 10.1093/emboj/17.3.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Prendergast P., Pan Z., Edwards D. P. Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms. Mol Endocrinol. 1996 Apr;10(4):393–407. doi: 10.1210/mend.10.4.8721984. [DOI] [PubMed] [Google Scholar]
  21. Quélo I., Kahlen J. P., Rascle A., Jurdic P., Carlberg C. Identification and characterization of a vitamin D3 response element of chicken carbonic anhydrase-II. DNA Cell Biol. 1994 Dec;13(12):1181–1187. doi: 10.1089/dna.1994.13.1181. [DOI] [PubMed] [Google Scholar]
  22. Rastinejad F., Perlmann T., Evans R. M., Sigler P. B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature. 1995 May 18;375(6528):203–211. doi: 10.1038/375203a0. [DOI] [PubMed] [Google Scholar]
  23. Read C. M., Cary P. D., Crane-Robinson C., Driscoll P. C., Norman D. G. Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Res. 1993 Jul 25;21(15):3427–3436. doi: 10.1093/nar/21.15.3427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schoenmakers E., Alen P., Verrijdt G., Peeters B., Verhoeven G., Rombauts W., Claessens F. Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains. Biochem J. 1999 Aug 1;341(Pt 3):515–521. [PMC free article] [PubMed] [Google Scholar]
  25. Schoenmakers E., Verrijdt G., Peeters B., Verhoeven G., Rombauts W., Claessens F. Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem. 2000 Apr 21;275(16):12290–12297. doi: 10.1074/jbc.275.16.12290. [DOI] [PubMed] [Google Scholar]
  26. Stros M. DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences. J Biol Chem. 1998 Apr 24;273(17):10355–10361. [PubMed] [Google Scholar]
  27. Sui X., Bramlett K. S., Jorge M. C., Swanson D. A., von Eschenbach A. C., Jenster G. Specific androgen receptor activation by an artificial coactivator. J Biol Chem. 1999 Apr 2;274(14):9449–9454. doi: 10.1074/jbc.274.14.9449. [DOI] [PubMed] [Google Scholar]
  28. Sutrias-Grau M., Bianchi M. E., Bernués J. High mobility group protein 1 interacts specifically with the core domain of human TATA box-binding protein and interferes with transcription factor IIB within the pre-initiation complex. J Biol Chem. 1999 Jan 15;274(3):1628–1634. doi: 10.1074/jbc.274.3.1628. [DOI] [PubMed] [Google Scholar]
  29. Thanos D., Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell. 1995 Dec 29;83(7):1091–1100. doi: 10.1016/0092-8674(95)90136-1. [DOI] [PubMed] [Google Scholar]
  30. Tsai M. J., O'Malley B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994;63:451–486. doi: 10.1146/annurev.bi.63.070194.002315. [DOI] [PubMed] [Google Scholar]
  31. Verrijdt G., Schoenmakers E., Haelens A., Peeters B., Verhoeven G., Rombauts W., Claessens F. Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J Biol Chem. 2000 Apr 21;275(16):12298–12305. doi: 10.1074/jbc.275.16.12298. [DOI] [PubMed] [Google Scholar]
  32. Wang Q., Lu J., Yong E. L. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region. J Biol Chem. 2000 Dec 1;276(10):7493–7499. doi: 10.1074/jbc.M009916200. [DOI] [PubMed] [Google Scholar]
  33. Wolffe A. P. Architectural regulations and Hmg1. Nat Genet. 1999 Jul;22(3):215–217. doi: 10.1038/10267. [DOI] [PubMed] [Google Scholar]
  34. Zappavigna V., Falciola L., Helmer-Citterich M., Mavilio F., Bianchi M. E. HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation. EMBO J. 1996 Sep 16;15(18):4981–4991. [PMC free article] [PubMed] [Google Scholar]
  35. Zhang C. C., Krieg S., Shapiro D. J. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol Endocrinol. 1999 Apr;13(4):632–643. doi: 10.1210/mend.13.4.0264. [DOI] [PubMed] [Google Scholar]
  36. Zwilling S., König H., Wirth T. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 1995 Mar 15;14(6):1198–1208. doi: 10.1002/j.1460-2075.1995.tb07103.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES